Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
15.35 AUD | +0.46% | +3.72% | +52.28% |
05-03 | Telix Pharmaceuticals Completes Acquisition of QSAM Biosciences and Drug Samarium-153-DOTMP | MT |
04-30 | Bell Potter Downgrades Telix Pharmaceuticals to Hold from Buy, Price Target is AU$14.50 | MT |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+52.28% | 3.32B | |
+22.56% | 46.71B | |
-1.51% | 41.52B | |
+48.83% | 41.8B | |
-3.42% | 29.55B | |
+10.13% | 25.78B | |
-20.44% | 19.26B | |
+26.45% | 11.98B | |
-0.14% | 12.14B | |
-0.47% | 12.08B |
- Stock Market
- Equities
- TLX Stock
- News Telix Pharmaceuticals Limited
- Transcript : Telix Pharmaceuticals Limited, 2023 Earnings Call, Feb 23, 2024